Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
dorsaVi Limited ( (AU:DVL) ) has shared an update.
dorsaVi Limited has announced the commencement of an evaluation program to scale its oxide-based RRAM from 40 nm to a 22 nm process node. This initiative aims to achieve higher density, lower energy consumption, and faster switching speeds, enhancing the company’s positioning in the embedded non-volatile memory and AI-driven systems markets. The 22 nm evaluation is expected to significantly improve device performance, battery life, and responsiveness, which could strengthen dorsaVi’s competitive edge in the wearables and industrial safety sectors.
More about dorsaVi Limited
dorsaVi Limited is a leader in FDA-approved wearable sensor technologies and motion intelligence, focusing on applications such as real-time biosignal processing and always-on motion intelligence for wearables and industrial safety. The company is known for its ViMove+ product and is expanding its presence in large clinic networks.
Average Trading Volume: 7,622,083
Technical Sentiment Signal: Buy
Current Market Cap: A$59.65M
Find detailed analytics on DVL stock on TipRanks’ Stock Analysis page.